{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:48:09Z","timestamp":1785754089813,"version":"3.56.0"},"reference-count":36,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"crossref","award":["2021QNB005"],"award-info":[{"award-number":["2021QNB005"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2026,8,3]]},"DOI":"10.1080\/14737140.2026.2630025","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:19:37Z","timestamp":1772774377000},"page":"1071-1078","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["The pricing barrier: cost-effectiveness of Glofitamab for relapsed\/refractory DLBCL in China beyond threshold and value-based pricing strategy considerations"],"prefix":"10.1080","volume":"26","author":[{"given":"Shen","family":"Lin","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Fujian Medical University","place":["Taijiang, Fuzhou, China"]},{"name":"Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Yang","sequence":"additional","affiliation":[{"name":"Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohong","family":"Luo","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Fujian Medical University","place":["Taijiang, Fuzhou, China"]},{"name":"Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Huang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Fujian Medical University","place":["Taijiang, Fuzhou, China"]},{"name":"Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-5281","authenticated-orcid":false,"given":"Xiuhua","family":"Weng","sequence":"additional","affiliation":[{"name":"Mengchao Hepatobiliary Hospital of Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4787-2506","authenticated-orcid":false,"given":"Xiongwei","family":"Xu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Fujian Medical University","place":["Taijiang, Fuzhou, China"]},{"name":"Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.1618"},{"key":"e_1_3_6_5_1","unstructured":"Roche Canada. COLUMVI\u00ae (glofitamab for injection) receives Health Canada authorization with conditions for adult patients with relapsed or refractory diffuse large B-cell lymphoma. Media release. 2023 Mar 25. Available from: https:\/\/www.rochecanada.com\/en\/media\/roche-canada-news\/COLUMVI-Glofitamab-for-Injection-Receives-Health-Canada-Authorization.html"},{"key":"e_1_3_6_6_1","unstructured":"Roche Canada. COLUMVI\u00ae product monograph. 2023. Available from: https:\/\/www.rochecanada.com\/content\/dam\/rochexx\/roche-ca\/products\/ConsumerInformation\/MonographsandPublicAdvisories\/columvi\/Columvi_PM_E.pdf"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01774-4"},{"key":"e_1_3_6_8_1","unstructured":"National Comprehensive Cancer Network (NCCN). Clinical practice guideline on oncology (B-Cell lymphomas). Version 2. 2025. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf"},{"key":"e_1_3_6_9_1","unstructured":"Guideline of Chinese society of clinical oncology lymphoid malignancies. Available from: https:\/\/www.csco.org.cn\/cn\/index.aspx"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X20978958"},{"key":"e_1_3_6_11_1","unstructured":"International monetary fund (IMF). [cited 2025 Jul 15]. Available from: https:\/\/www.imf.org\/en\/Home"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2023.02.006"},{"key":"e_1_3_6_13_1","unstructured":"PharmInfo data official website - data service provider for the pharmaceutical and healthcare industry. [cited 2025 Jul 15]. Available from: https:\/\/db.yaozh.com\/"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2023.2207742"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2023-0073"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.923619"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.594756"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0321"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2019.05.027"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.09.016"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1390230"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-024-01866-y"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-086251"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2023.186"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2694"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0027-x"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00286-9"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.819674"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1213318"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac219"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1297405"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-023-00442-y"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2019.1680288"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2020.1715536"},{"key":"e_1_3_6_35_1","unstructured":"Nation aims to improve cancer survival rates. [cited 2025 Jul 15]. Available from: https:\/\/english.www.gov.cn\/news\/202311\/16\/content_WS655578fec6d0868f4e8e148d.html"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02201-6"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0946"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2023.2166375"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2026.2630025","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14737140.2026.2630025","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2026.2630025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:23:13Z","timestamp":1785752593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2026.2630025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"alternative-id":["10.1080\/14737140.2026.2630025"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2026.2630025","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}